Glen Tullman, Transcarent CEO
January 8, 2025 12:23 PM ESTUpdated 03:15 PM
Deals
Health Tech

Tran­scar­ent buys health nav­i­ga­tion in­cum­bent Ac­co­lade for $621M

Ngai Yeung

Health Tech Reporter

Uni­corn start­up Tran­scar­ent has bought up a pub­licly trad­ed ri­val as it looks to ex­pand as a health nav­i­ga­tion gi­ant in one of the first …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ex­clu­sive: Drug­mak­ers plan Trump meet­ing next week amid Wash­ing­ton health shake­ups

Health­care shake­up hits Wash­ing­ton, with cuts at CDC, NIH and oth­er agen­cies

Ko­jin Ther­a­peu­tics shuts down, cit­ing lack of in­vestor in­ter­est and com­plex sci­ence

BioN­Tech vets raise $90M Se­ries A for bis­pe­cif­ic I&I start­up

ARPA-H chief is out as Trump ad­min­is­tra­tion cuts health agen­cies

sponsored

Re­duc­ing risk in drug de­vel­op­ment: The im­por­tance of val­i­dat­ed MRD test­ing in lym­phoid can­cers

A service from the Financial Times